Doctoral students from VP&S and Mailman participated in a university-wide competition designed to help students develop communication skills for future careers. Two shared top honors.
Based on an analysis of withdrawn drugs that gained approval through the FDA's fast-track program, Columbia researchers argue that such programs have positively contributed to drug development.
A team of Columbia scientists is examining patient samples and experimenting with organoids to understand why colon cancer is on the rise in people under 50.
Columbia MD/PhD student Deirdre Ricaurte is using new genomics methods to understand how prescription drugs disturb our gut microbiome and the health consequences of these “drug-bug” interactions.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
A study by Columbia researchers found that prenatal exposure to general anesthesia is associated with a 31% increased risk of being diagnosed with a behavioral disorder during childhood.
Just before turning 40, Larry Abbott switched from physics to theoretical neuroscience. Now, a few decades later, his contributions to brain science have been recognized with the 2024 Brain Prize.
Columbia neuroscientists have uncovered evidence for a new form of collective sensing that appears to enable elephantnose fish to extend their perceptual reach.
In tests with mice, inhalable exosomes created by Columbia biomedical engineers successfully delivered cancer treatment to the lungs and suppressed tumor growth without toxic side effects.
A study of people with obstructive sleep apnea suggests that high CPAP pressures may explain why the machines do not lower a patient’s risk of heart disease.